Last synced on 2 May 2025 at 11:05 pm

Enzyme Immunoassay, Oxcarbazepine Metabolite

Page Type
Product Code
Definition
An Oxcarbazepine Metabolite Assay is an enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.
Physical State
In vitro reagents
Technical Method
Enzyme immunoassay
Target Area
For in vitro diagnostic use only
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3645
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3645 Neuroleptic drugs radioreceptor assay test system

§ 862.3645 Neuroleptic drugs radioreceptor assay test system.

(a) Identification. A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.

(b) Classification. Class II.

Enzyme Immunoassay, Oxcarbazepine Metabolite

Page Type
Product Code
Definition
An Oxcarbazepine Metabolite Assay is an enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.
Physical State
In vitro reagents
Technical Method
Enzyme immunoassay
Target Area
For in vitro diagnostic use only
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3645
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3645 Neuroleptic drugs radioreceptor assay test system

§ 862.3645 Neuroleptic drugs radioreceptor assay test system.

(a) Identification. A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.

(b) Classification. Class II.